EICHOR ● Active Not Recruiting

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

Condition: Lupus Nephritis · Sponsor: AstraZeneca

PhasePhase 3

Planned participants363

Who can joinAll sexes, 18 Years to 70 Years

Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy and safety of IV antifrolumab in adult patients with Active Proliferative Lupus Nephritis

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (164)

Research Site	Glendale, Arizona, United States	—
Research Site	La Palma, California, United States	—
Research Site	Los Angeles, California, United States	—
Research Site	Upland, California, United States	—
Research Site	Plantation, Florida, United States	—
Research Site	Atlanta, Georgia, United States	—
Research Site	Louisville, Kentucky, United States	—
Research Site	Summit, New Jersey, United States	—
Research Site	Manhasset, New York, United States	—
Research Site	New York, New York, United States	—
Research Site	Winston-Salem, North Carolina, United States	—
Research Site	Middleburg Heights, Ohio, United States	—

+ 152 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →